NCATS announces funding for Pre-clinical Research Based on Existing Repurposing Tools
Mon, Nov 2, 2015
The NIH - National Center for Advancing Translational Sciences (NCATS) announces the availability of funding for Pre-clinical Research Based on Existing Repurposing Tools (R21) - RFA-TR-16-001. This Funding Opportunity Announcement (FOA) will support rigorous, pre-clinical studies that establish the rationale for a clinical trial, where the hypothesis originates from use of a published or publicly available method for identifying new indications for existing drugs or biologics (therapeutics). Due Date: LOI due December 13, 2015 Amount of Funding: $400,000 over two years. More Details
Back to NewsThe NIH - National Center for Advancing Translational Sciences (NCATS) announces the availability of funding for Pre-clinical Research Based on Existing Repurposing Tools (R21) - RFA-TR-16-001. This Funding Opportunity Announcement (FOA) will support rigorous, pre-clinical studies that establish the rationale for a clinical trial, where the hypothesis originates from use of a published or publicly available method for identifying new indications for existing drugs or biologics (therapeutics). Due Date: LOI due December 13, 2015 Amount of Funding: $400,000 over two years. More Details